Posts tagged ‘Market Assessment’
March 7th, 2011
When we do a market assessment or commercial landscape for a therapeutic area or new product, one of the things we look at is emerging new treatments or diagnostics. It’s important to understand the impact these may have on the market opportunity.
Recent research published in the AACR journal Clinical Cancer Research suggests that Engrailed-2 (EN2) may have potential as a biomarker for the diagnosis and treatment of prostate cancer (PC).
In a post on Biotech Strategy Blog, Pieter Droppert discusses the clinical data comparing EN2 to measurement of serum prostate specific antigen (PSA).
Clinical Research Integrity is essential to bring novel Pharma, Biotech and Medical Device Products to Market
March 6th, 2011
News that a leading German anesthesiologist has undertaken multiple clinical trials, including some that appear to have been industry sponsored, without proper ethics committee/institutional review board consent is a cause for concern.
The pharma, biotech and medical device industries rely on the integrity of the clinical research process, and this type of news undermines public confidence in clinical trials.
You can read more about this breaking story on Biotech Strategy Blog.